N@N

Enzon to Release First Quarter 2010 Earnings on Monday, May 10, 2010; Conference Call and Webcast to Follow

_{//health-fitness.news-articles.net/content/2010/ .. -2010-conference-call-and-webcast-to-follow.html}
^{Published in Health and Fitness on Thursday, May 6th 2010 at 19:40 GMT by Market Wire}  

BRIDGEWATER, N.J.--([ BUSINESS WIRE ])--Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) announced today that it will report its financial results for the quarter ended March 31, 2010, on Monday, May 10, 2010 at approximately 8:00 am Eastern Time (ET). The release will be followed by a live conference call, which will begin at approximately 5:00 pm Eastern Time (ET) on Monday, May 10, 2010.

All interested parties may access the call by using the following information:

The call will also be available live audio webcast at [ http://investor.enzon.com/eventdetail.cfm?eventid=81017 ]. Listeners should go to the website at least fifteen minutes before this event to download and install any necessary audio software. For those unable to attend the live audio webcast, a replay will be available beginning approximately one hour after the event. Additionally, a telephonic rebroadcast will also be available following the call. The rebroadcast will begin on Tuesday, May, 11, 2010 at approximately 8:00 am Eastern Time (ET) and end on Monday, May 17, 2010 at approximately 12:00 pm Eastern Time (ET). It may be accessed using the following information:

About Enzon

Enzon Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery and development of innovative medicines for patients with cancer. Enzona™s drug development programs utilize several cutting-edge approaches, including its industry-leading PEGylation technology platform, Customized Linker technologya" and mRNA antagonists using the Locked Nucleic Acida" (LNA) technology. Enzona™s receives a royalty revenue stream from licensing partnerships for other products developed using the proprietary PEGylation technology. Further information about Enzon and this press release can be found on the Companya™s web site at [ www.enzon.com ].